201 related articles for article (PubMed ID: 21113760)
21. Physical activity and cancer prevention--data from epidemiologic studies.
Lee IM
Med Sci Sports Exerc; 2003 Nov; 35(11):1823-7. PubMed ID: 14600545
[TBL] [Abstract][Full Text] [Related]
22. Surgical management of recurrent genitourinary malignancies.
Greenberg RE; Charles RS; Samaha AM; Chelsky M; Rosen S
Semin Oncol; 1993 Oct; 20(5):473-92. PubMed ID: 8211196
[No Abstract] [Full Text] [Related]
23. Factors associated with suicide in patients with genitourinary malignancies.
Klaassen Z; Jen RP; DiBianco JM; Reinstatler L; Li Q; Madi R; Lewis RW; Smith AM; Neal DE; Moses KA; Terris MK
Cancer; 2015 Jun; 121(11):1864-72. PubMed ID: 25690909
[TBL] [Abstract][Full Text] [Related]
24. Genitourinary cancer: a brief review.
Merrill JM
Compr Ther; 1981 Mar; 7(3):40-4. PubMed ID: 7195323
[No Abstract] [Full Text] [Related]
25. Chemoprevention of urological cancer.
Kamat AM; Lamm DL
J Urol; 1999 Jun; 161(6):1748-60. PubMed ID: 10332429
[TBL] [Abstract][Full Text] [Related]
26. The potential role of cyclooxygenase-2 inhibitors and 5alpha-reductase inhibitors in the prevention of urologic conditions.
Hernandez J; Basler JW; Thompson IM
Urol Clin North Am; 2004 May; 31(2):213-8. PubMed ID: 15123401
[TBL] [Abstract][Full Text] [Related]
27. Bibliography. Current world literature. Genitourinary system.
Curr Opin Oncol; 2005 May; 17(3):292-318. PubMed ID: 15934139
[No Abstract] [Full Text] [Related]
28. Genitourinary cancer.
Ozols RF; Yagoda A
Cancer Chemother Biol Response Modif; 1988; 10():271-90. PubMed ID: 2856330
[No Abstract] [Full Text] [Related]
29. Activities and accomplishments of the cancer and leukemia group B genitourinary committee.
Small EJ; Halabi S; Kantoff P; D'Amico A; Stadler W; Kelley WK; Mohler J; Bajorin D; Vogelzang NJ
Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3596s-600s. PubMed ID: 16740791
[TBL] [Abstract][Full Text] [Related]
30. Genitourinary system.
Curr Opin Oncol; 1995 May; 7(3):B59-68. PubMed ID: 7654818
[No Abstract] [Full Text] [Related]
31. Expression and clinical significance of CD147 in genitourinary carcinomas.
Han ZD; He HC; Bi XC; Qin WJ; Dai QS; Zou J; Ye YK; Liang YX; Zeng GH; Zhu G; Chen ZN; Zhong WD
J Surg Res; 2010 May; 160(2):260-7. PubMed ID: 19286191
[TBL] [Abstract][Full Text] [Related]
32. Circumvention of multidrug resistance in genitourinary tumors.
van Brussel JP; Mickisch GH
Int J Urol; 1998 Jan; 5(1):1-15. PubMed ID: 9535594
[TBL] [Abstract][Full Text] [Related]
33. Therapy and prognosis of tumors of the genitourinary tract after kidney transplantation.
Diller R; Gruber A; Wolters H; Senninger N; Spiegel HU
Transplant Proc; 2005 Jun; 37(5):2089-92. PubMed ID: 15964347
[TBL] [Abstract][Full Text] [Related]
34. Biologic tools to personalize treatment in genitourinary cancers.
Bracarda S; Sisani M; Del Buono S; Ishiwa O; Montagnani F;
Crit Rev Oncol Hematol; 2012 Dec; 84 Suppl 1():e42-8. PubMed ID: 21232974
[TBL] [Abstract][Full Text] [Related]
35. Practical Molecular Testing in a Clinical Genitourinary Service.
Magers MJ; Cheng L
Arch Pathol Lab Med; 2020 Mar; 144(3):277-289. PubMed ID: 31373513
[TBL] [Abstract][Full Text] [Related]
36. [Secondary prevention after urological tumor diseases. Focusing on the kidneys, testes, and bladder].
Mathers MJ; Lazica DA; Klotz T; Sommer F; Roth S
Urologe A; 2007 Jun; 46(6):636-41. PubMed ID: 17487469
[TBL] [Abstract][Full Text] [Related]
37. Maximizing outcomes in genitourinary cancers across the treatment continuum.
Fitzpatrick JM; Bellmunt J; Dreicer R; Fleshner NE; Logothetis CJ; Moul JW; Tombal B; Zlotta A
BJU Int; 2011 Apr; 107 Suppl 2():1-12. PubMed ID: 21382149
[TBL] [Abstract][Full Text] [Related]
38. Incidence of urogenital cancers in Gunma Prefecture, Japan: a 10-year summary.
Nakata S; Ohtake N; Kubota Y; Imai K; Yamanaka H; Ito Y; Hirayama N; Hasegawa K
Int J Urol; 1998 Jul; 5(4):364-9. PubMed ID: 9712446
[TBL] [Abstract][Full Text] [Related]
39. Genitourinary rhabdomyosarcoma in children.
LaQuaglia M
Urol Clin North Am; 1991 Aug; 18(3):575-80. PubMed ID: 1877121
[TBL] [Abstract][Full Text] [Related]
40. Cyclooxygenase-2 as a potential target in the prevention and treatment of genitourinary tumors: a review.
Pruthi RS; Derksen E; Gaston K
J Urol; 2003 Jun; 169(6):2352-9. PubMed ID: 12771797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
